Indobufen-based dual antiplatelet therapy after percutaneous coronary intervention: A systematic review and network meta-analysis
Indobufen-based DAPT was comparable, not superior, to aspirin plus clopidogrel across bleeding and ischaemic outcomes, with no signal of increased ischaemic risk.